Analystreport

DiaMedica Therapeutics Inc (NASDAQ: DMAC) had its "buy" rating re-affirmed by analysts at Maxim Group.

DiaMedica Therapeutics Inc.  (DMAC) 
Last diamedica therapeutics inc. earnings: 11/13 04:12 pm Check Earnings Report